skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
15524707
Filing Dt:
05/05/2017
Publication #:
Pub Dt:
01/03/2019
Inventors:
James E. Bradner, Bruce Blazar, Ryan Flynn, Jun Qi
Title:
USE OF COMPOSITIONS MODULATING CHROMATIN STRUCTURE FOR GRAFT VERSUS HOST DISEASE (GVHD)
Assignment: 1
Reel/Frame:
046935/0981Recorded: 09/21/2018Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/19/2015
Exec Dt:
11/19/2015
Assignee:
600 MCNAMARA ALUMNI CENTER
200 OAK STREET SE
MINNEAPOLIS, MINNESOTA 55455-2020
Correspondent:
JESSICA CHAO
WOLF, GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON, MA 02210
Assignment: 2
Reel/Frame:
046938/0347Recorded: 09/21/2018Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/23/2015
Exec Dt:
11/23/2015
Assignee:
450 BROOKLINE AVENUE
BOSTON, MASSACHUSETTS 02215
Correspondent:
JESSICA CHAO
WOLF, GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON, MA 02210
Assignment: 3
Reel/Frame:
057493/0188Recorded: 09/13/2021Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
02/05/2019
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/13/2024 11:41 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT